Global Lung Cancer Surgery Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Lung Cancer Surgery Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Type (Thoracotomy (Lobectomy, Sleeve Resection, Segmentectomy, and Pneumonectomy), and Minimally Invasive Surgeries)), Product (Surgical Devices, and Monitoring Devices), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Lung Cancer Surgery Market was valued at USD 6,075.8 million in 2023 and is expected to reach USD 8,463.4 million by 2031 while growing at a CAGR of 4.2% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global lung cancer surgery market growth. Lung cancer surgery involves removing tumors or cancerous tissues from the lungs to eliminate or reduce cancer cell presence. It is a vital part of comprehensive lung cancer treatment plans and is often combined with chemotherapy and radiation therapy based on the cancer stage and type.
The increasing incidence of lung cancer, coupled with technological advancements and improved healthcare infrastructure, is driving substantial growth in the lung cancer surgery market. Despite these positive factors, the market expansion may encounter hurdles such as the risk of surgical complications and the high cost of lung cancer treatment.
Furthermore, the global lung cancer surgery industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Type Analysis
The Global Lung Cancer Surgery Market is segmented among Thoracotomy, and Minimally Invasive Surgeries, based on type. In 2023, Thoracotomy accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Product Analysis
The Global Lung Cancer Surgery Market is segmented among Surgical Devices, and Monitoring Devices, based on product. In 2023, Surgical Devices accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Lung Cancer Surgery Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Accuray Incorporated, GE Healthcare, Johnson & Johnson, Olympus Corporation, Richard Wolf GmbH, Siemens Healthineers AG, and AngioDynamics Inc.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Lung Cancer Surgery Market Dynamics
Drivers
Restraints
Opportunity
4. Global Lung Cancer Surgery Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Lung Cancer Surgery Market Segmentation, By Type
Global Lung Cancer Surgery Market Share Analysis, By Type
Global Lung Cancer Surgery Market Growth Analysis, By Type
Global Lung Cancer Surgery Market Trends, By Type
o Thoracotomy
Ø Lobectomy
Ø Sleeve Resection
Ø Segmentectomy
Ø Pneumonectomy
o Minimally Invasive Surgeries
6. Global Lung Cancer Surgery Market Segmentation, By Product
Global Lung Cancer Surgery Market Share Analysis, By Product
Global Lung Cancer Surgery Market Growth Analysis, By Product
Global Lung Cancer Surgery Market Trends, By Product
o Surgical Devices
o Monitoring Devices
7. Global Lung Cancer Surgery Market Segmentation, By Region
Global Lung Cancer Surgery Market Share Analysis, By Region
Global Lung Cancer Surgery Market Growth Analysis, By Region
Global Lung Cancer Surgery Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
8. Competitive Landscape
Accuray Incorporated*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
GE Healthcare
Johnson & Johnson
Olympus Corporation
Richard Wolf GmbH
Siemens Healthineers AG
AngioDynamics Inc.
*Similar analysis will be provided for each company listed above.